InsiderClue
Insiders · Profile

Decheng Capital Global Life Sciences Fund IV, L.P.

10% owner at Aardvark Therapeutics · 10% owner at CG Oncology. Filing since 29 Jan 2024. CIK 0001834150

AARD Aardvark Therapeutics, Inc. 10% owner · 1 trade CGON CG Oncology, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
AARD Aardvark Therapeutics, Inc.
14 Feb 2025
10% owner
Bought
1,250,000
$20.00M
73.1%
CGON CG Oncology, Inc.
29 Jan 2024
10% owner
Bought
400,000
$7.60M
opened
2 decisions on file.